IMPAX Laboratories, Inc. Confirms Patent Challenge Relating to ORACEA(R) Delayed-Release Capsules, 40mg

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its ORACEA® (doxycycline) delayed-release capsules, 40 mg.